424B5The Raise
Damora Therapeutics, Inc. files 424B5
Filed Feb 11, 2026 · 4mo ago · Accession 0001193125-26-046779
Plain English
424B5 filed with the SEC.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 424B5
- Filing date
- Feb 11, 2026
- Report date
- —
- Document
- d41040d424b5.htm
- Size
- 3.1 MB